DSGN vs GERN: stock comparison and AI forecast
Design Therapeutics, Inc. (DSGN) and Geron Corp (GERN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
DSGN Design Therapeutics, Inc.
- Market Cap
- $665M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
GERN Geron Corp
- Market Cap
- $694M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- DSGN and GERN have similar market capitalizations ($665M and $694M).
- GERN carries 1.33 times debt per unit of equity, against 0.07 times for DSGN.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | DSGN | GERN |
|---|---|---|
| Market Cap | $665M | $694M |
| P/B Ratio | 3.29x | 3.06x |
| EPS | $-1.24 | $-0.10 |
| Book Value/Share | $3.23 | $0.35 |
| Revenue/Share | $0.00 | – |
| FCF/Share | $-0.95 | – |
Profitability & Margins
| Metric | DSGN | GERN |
|---|---|---|
| ROE | -36.6% | -37.6% |
| ROA | -34.2% | -16.2% |
| ROIC | -40.3% | -7.1% |
| Operating Margin | – | -15.6% |
| Net Margin | – | -41.1% |
| EBT Margin | – | -22.6% |
Financial Health
| Metric | DSGN | GERN |
|---|---|---|
| Current Ratio | 16.78x | 6.31x |
| Quick Ratio | – | 4.61x |
| D/E Ratio | 0.07x | 1.33x |
| Financial Leverage | 1.07x | 2.33x |
| Interest Coverage | – | -2.2x |
| Working Capital | $201M | $394M |
Cash Flow
| Metric | DSGN | GERN |
|---|---|---|
| Operating Cash Flow | -$59M | -$91M |
| Free Cash Flow | -$59M | – |
| Capital Spending | -$70K | – |
Operational Efficiency
| Metric | DSGN | GERN |
|---|---|---|
| Asset Turnover | 0.00x | – |
| Fixed Assets Turnover | 0.0x | – |
Income Statement
| Metric | DSGN | GERN |
|---|---|---|
| Total Revenue | $0.00M | – |
| Operating Income | -$82M | -$32M |
| Net Income | -$74M | -$85M |
| R&D Expense | $61M | $63M |
| SG&A Expense | – | $152M |
Dividend & Shareholder Information
| Metric | DSGN | GERN |
|---|---|---|
| Shares Outstanding | 63M | 642M |
DSGN vs GERN: stock comparison and AI forecast
Which is bigger, DSGN or GERN?
DSGN and GERN have similar market capitalizations ($665M and $694M).
Which one does Intratio's AI model rank higher, DSGN or GERN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.